M&R Capital Management’s Biogen BIIB Stock Holding History

M&R Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300	Closed	-$93K	–	552
2016 Q3	$93K	Hold	300	–	–	0.03%	219
2016 Q2	$72K	Buy	+300	New	+$79.1K	0.02%	248
2015 Q3	–	Sell	-1,000	Closed	-$404K	–	189
2015 Q2	$404K	Hold	1,000	–	–	0.1%	140
2015 Q1	$422K	Hold	1,000	–	–	0.1%	143
2014 Q4	$339K	Hold	1,000	–	–	0.08%	156
2014 Q3	$331K	Hold	1,000	–	–	0.08%	157
2014 Q2	$315K	Buy	+1,000	New	+$301K	0.07%	162
2014 Q1	–	Sell	-1,000	Closed	-$280K	–	206
2013 Q4	$280K	Buy	+1,000	New	+$259K	0.07%	163

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

M&R Capital Management's BIIB Position: Q4 2016 in Review

M&R Capital Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 300 shares — an estimated $93K sold.

M&R Capital Management first reported a position in BIIB in Q4 2013 and held it in 8 quarters. The position peaked at $422K in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

M&R Capital Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
M&R Capital Management sold 300 Biogen shares in Q4 2016, an estimated $93K.
M&R Capital Management first reported a position in Biogen in Q4 2013 and held it in 8 quarters.
M&R Capital Management's Biogen position peaked at $422K in Q1 2015.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on M&R Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.